Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study

Osteoarthritis (OA) is a major source of chronic pain and disability, representing a significant global health concern that affects 10–15 % of individuals aged over 60, with a higher prevalence among females than males. This investigation aimed to evaluate the impact of a dietary supplement containi...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Antonio Carrillo-Norte, Guillermo Gervasini-Rodríguez, María Ángeles Santiago-Triviño, Virginio García-López, Rafael Guerrero-Bonmatty
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Contemporary Clinical Trials Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865424001716
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545485046775808
author Juan Antonio Carrillo-Norte
Guillermo Gervasini-Rodríguez
María Ángeles Santiago-Triviño
Virginio García-López
Rafael Guerrero-Bonmatty
author_facet Juan Antonio Carrillo-Norte
Guillermo Gervasini-Rodríguez
María Ángeles Santiago-Triviño
Virginio García-López
Rafael Guerrero-Bonmatty
author_sort Juan Antonio Carrillo-Norte
collection DOAJ
description Osteoarthritis (OA) is a major source of chronic pain and disability, representing a significant global health concern that affects 10–15 % of individuals aged over 60, with a higher prevalence among females than males. This investigation aimed to evaluate the impact of a dietary supplement containing collagen peptides (MW 1–3 kDa) on knee OA symptoms and inflammatory biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Adults aged 30–81 years (50 % female) with grade II or III OA and a minimum pain score of 40 on the 0 to 100 visual analogue scale (VAS) were enrolled. Participants were randomly assigned to receive either 10 g of the test product (verum group) or placebo and were assessed at baseline (T0, pre-treatment) and after a six-month follow-up period (T6). Baseline characteristics were comparable between groups. At T6, the verum group exhibited significant reductions in VAS pain scores, Lequesne algofunctional index (LAI) scores, CRP levels (mg/L), and ESR (mm/h) compared to placebo (p < 0.001). No adverse effects were reported during the study, and the supplement demonstrated good tolerability and yielded satisfactory safety and acceptability. These findings suggest that the dietary supplement may serve as a complement to drug therapy for knee OA by alleviating osteoarticular pain, improving locomotor function and potentially reducing reliance on analgesic and anti-inflammatory medications. This study provides valuable insights into the efficacy and safety of collagen peptides in managing knee OA symptoms.
format Article
id doaj-art-11326b56b9164f9b9c832be741d6ee2c
institution Kabale University
issn 2451-8654
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Contemporary Clinical Trials Communications
spelling doaj-art-11326b56b9164f9b9c832be741d6ee2c2025-01-12T05:25:31ZengElsevierContemporary Clinical Trials Communications2451-86542025-02-0143101424Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled studyJuan Antonio Carrillo-Norte0Guillermo Gervasini-Rodríguez1María Ángeles Santiago-Triviño2Virginio García-López3Rafael Guerrero-Bonmatty4Department of Medical and Surgical Therapeutics, Division of Clinical Pharmacology, School of Medicine, University of Extremadura, Badajoz, Spain; Corresponding author.Department of Medical and Surgical Therapeutics, Division of Clinical Pharmacology, School of Medicine, University of Extremadura, Badajoz, SpainIntensive Care Unit, University Hospital of Badajoz, SpainDepartment of Medical and Surgical Therapeutics, Division of Clinical Pharmacology, School of Medicine, University of Extremadura, Badajoz, SpainDepartment of Nursing, School of Nursing, University of Extremadura, Mérida, SpainOsteoarthritis (OA) is a major source of chronic pain and disability, representing a significant global health concern that affects 10–15 % of individuals aged over 60, with a higher prevalence among females than males. This investigation aimed to evaluate the impact of a dietary supplement containing collagen peptides (MW 1–3 kDa) on knee OA symptoms and inflammatory biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Adults aged 30–81 years (50 % female) with grade II or III OA and a minimum pain score of 40 on the 0 to 100 visual analogue scale (VAS) were enrolled. Participants were randomly assigned to receive either 10 g of the test product (verum group) or placebo and were assessed at baseline (T0, pre-treatment) and after a six-month follow-up period (T6). Baseline characteristics were comparable between groups. At T6, the verum group exhibited significant reductions in VAS pain scores, Lequesne algofunctional index (LAI) scores, CRP levels (mg/L), and ESR (mm/h) compared to placebo (p < 0.001). No adverse effects were reported during the study, and the supplement demonstrated good tolerability and yielded satisfactory safety and acceptability. These findings suggest that the dietary supplement may serve as a complement to drug therapy for knee OA by alleviating osteoarticular pain, improving locomotor function and potentially reducing reliance on analgesic and anti-inflammatory medications. This study provides valuable insights into the efficacy and safety of collagen peptides in managing knee OA symptoms.http://www.sciencedirect.com/science/article/pii/S2451865424001716Collagen peptidesDietary supplementKnee osteoarthritisJoint painJoint functional limitation
spellingShingle Juan Antonio Carrillo-Norte
Guillermo Gervasini-Rodríguez
María Ángeles Santiago-Triviño
Virginio García-López
Rafael Guerrero-Bonmatty
Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study
Contemporary Clinical Trials Communications
Collagen peptides
Dietary supplement
Knee osteoarthritis
Joint pain
Joint functional limitation
title Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study
title_full Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study
title_fullStr Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study
title_full_unstemmed Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study
title_short Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study
title_sort oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis results from a randomized double blind placebo controlled study
topic Collagen peptides
Dietary supplement
Knee osteoarthritis
Joint pain
Joint functional limitation
url http://www.sciencedirect.com/science/article/pii/S2451865424001716
work_keys_str_mv AT juanantoniocarrillonorte oraladministrationofhydrolyzedcollagenalleviatespainandenhancesfunctionalityinkneeosteoarthritisresultsfromarandomizeddoubleblindplacebocontrolledstudy
AT guillermogervasinirodriguez oraladministrationofhydrolyzedcollagenalleviatespainandenhancesfunctionalityinkneeosteoarthritisresultsfromarandomizeddoubleblindplacebocontrolledstudy
AT mariaangelessantiagotrivino oraladministrationofhydrolyzedcollagenalleviatespainandenhancesfunctionalityinkneeosteoarthritisresultsfromarandomizeddoubleblindplacebocontrolledstudy
AT virginiogarcialopez oraladministrationofhydrolyzedcollagenalleviatespainandenhancesfunctionalityinkneeosteoarthritisresultsfromarandomizeddoubleblindplacebocontrolledstudy
AT rafaelguerrerobonmatty oraladministrationofhydrolyzedcollagenalleviatespainandenhancesfunctionalityinkneeosteoarthritisresultsfromarandomizeddoubleblindplacebocontrolledstudy